Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach.

The effective half-life of radioactive iodine for (near) thyroidectomy patients was evaluated using an in vivo gamma camera approach. Five patients with post administered iodine for remnant ablation of thyroid were thoroughly scanned in vivo for one to four weeks. Derived data were analyzed in a MATLAB program to revise the ICRP recommended effective half-life and, thus, to offer a more reliable dose predication protocol from a health physics viewpoint. A quantitative index, AT (Agreement), was also introduced to specify the deviation between the actual measurement and the results fitted in MATLAB for each patient. The ATs were evaluated as 1.52 +/- 1.54 and 14.05 +/- 11.01 for the thyroid compartment and the remainder, re-spectively, indicating a slight discrepancy between the computed and practical results for the remainder. The actual effective half-life of iodine in the thyroid or the body fluid compartment shifted from 7.3d or 0.24 d to only 0.61 +/- 0.50 d or 0.49 +/- 0.23 d, respectively. Additionally, the integrated T(eff) for the remainder (both body fluid and whole body compartments) was still about 5.8d, since the body fluid and the whole body compartment was inseparable in real whole body scanning. The branching ratio from body fluid compartment to the thyroid and the excretion compartment also changed from 30% and 70% to 11.6 +/- 14.0% and 88.4 +/- 14.6%, respectively. The thyroid was the dominant compartment for a healthy person in the traditional biokinetic model. However, this dominant compartment was shifted to both thyroid and body fluid, based on analyses of the data following thyroidectomy, for the patients herein.

[1]  Lung Kwang Pan,et al.  Trace elements of Taiwanese dioscorea spp. using instrumental neutron activation analysis , 2001 .

[2]  G. Chabot,et al.  An alternative method for the release criteria and calculation of the total dose equivalent to another individual from a patient treated with a therapeutic dose of 131I. , 2001, Health physics.

[3]  K. Kamiya,et al.  Age-dependent exposure to radioactive iodine (131I) in the thyroid and total body of newborn, pubertal and adult fischer 344 rats. , 2001, Journal of radiation research.

[4]  D R Shearer,et al.  Effective half-life of 131I in thyroid cancer patients. , 2001, Health physics.

[5]  P. Zanzonico,et al.  Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine. , 2000, Health physics.

[6]  B. de Keizer,et al.  Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy , 2000, Nuclear medicine communications.

[7]  M. Schlumberger,et al.  Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.

[8]  Herbert Malamud,et al.  MIRD Primer for Absorbed Dose Calculations , 1989 .

[9]  E. Mazzaferri,et al.  Pure follicular thyroid carcinoma: impact of therapy in 214 patients. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  G. Berg,et al.  Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A. Wambersie,et al.  Recommended restrictions after 131I therapy: measured doses in family members. , 1999, Health physics.

[12]  Lung Kwang Pan,et al.  Verification of the Neutron Flux of a Modified Zero-Power Reactor Using a Neutron Activation Method , 2000 .

[13]  G H Kramer,et al.  Biological half-life of iodine in adults with intact thyroid function and in athyreotic persons. , 2002, Radiation protection dosimetry.

[14]  Y. Erdi,et al.  Radiation Dose Assessment for I-131 Therapy of Thyroid Cancer Using I-124 PET Imaging. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[15]  Howard S. Smith,et al.  Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. , 1990, Endocrinology and metabolism clinics of North America.

[16]  Lung Kwang Pan,et al.  Effective Half-Life of 131I of Whole-body and Individual Organs for Thyroidectomy Patient Using Scintigraphic Images of γ-camera , 2003 .

[17]  A. Introduction RELEASE OF PATIENTS ADMINISTERED RADIOACTIVE MATERIALS , 1997 .

[18]  P. V. Ramzaev,et al.  Limits for intakes of radionuclides by workers. , 1981, Annals of the ICRP.